Kanuma intravenous infusion 20mg, containing Sebelipase alpha (genetically recombined), is manufactured by Alexion Pharma. This injectable drug, with YJ code 3959419A1026 and standard 20mg 10mL x 1 bottle, is a recombinant lysosomal acid lipase used for long-term enzyme replacement therapy in patients with lysosomal acid lipase (LAL) deficiency.
Kanuma intravenous infusion 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →